Keep Factually independent
Whether you agree or disagree with our analysis, these conversations matter for democracy. We don't take money from political groups - even a $5 donation helps us keep it that way.
Which supplements have clinical trials showing increased semen volume in men over 50?
Executive summary
Available reporting shows very limited high-quality clinical-trial evidence that any over‑the‑counter supplement reliably increases semen volume specifically in men over 50. Most coverage highlights a small number of company‑sponsored trials of branded products (notably Semenax) enrolling mixed-age adults up to about 60, while independent reviews and journalists warn that comprehensive trials focused on older men are scarce [1] [2] [3] [4].
1. What trials exist — and who ran them?
Marketing and press releases repeatedly point to a two‑month, double‑blind, placebo‑controlled trial of Semenax (63 men aged 30–60) as the most frequently cited clinical study supporting a supplement claim; this trial is described in company and distributor materials as showing improvements in ejaculatory function and semen volume over 8 weeks [1] [2]. Other “clinically reviewed” roundups and PR pieces list products like Semenoll, Volume Pills and similar formulas and sometimes allege clinical backing, but these are largely promotional or secondary summaries rather than independent peer‑reviewed clinical trials [5] [6] [7].
2. Age coverage: are men over 50 well represented?
Available trial descriptions cited in the press include participants “aged 30–60” or similar ranges [1]. That means men over 50 may have been included, but the reporting does not present outcomes broken down by decade or isolate effects specifically in men >50; sources do not provide trial subgroup data for that age group [1]. Independent reviewers and critical overviews explicitly note that most evidence comes from mixed‑age samples or from ingredient studies rather than head‑to‑head trials in older men [4] [8].
3. Independent expert caution and safety context
Journalistic coverage and health reporting urge caution: urologists and reviewers say many load‑boosting supplements overpromise, safety and interactions matter—especially for older men who are more likely to be on medications or have prostate issues [3] [4]. Men’s Health notes age‑related declines in semen volume are common and that supplements’ claims should be viewed skeptically without robust independent trials [3]. Review sites also emphasize that most evidence is for isolated ingredients or small studies, not the final commercial formulations [4] [8].
4. Which ingredients have some supporting studies — but not definitive proof for older men?
Several reviews and supplement summaries mention ingredients with preliminary or isolated evidence—zinc, L‑citrulline/arginine, maca, tribulus and B12 among them—but they point out that most clinical data are limited to surrogate endpoints (semen parameters, sperm count or concentration) and not large, age‑stratified, placebo‑controlled trials of finished products in men over 50 [9] [4] [8]. The sources state that comprehensive clinical trials on complete supplement formulas remain limited [4].
5. Marketing vs. peer‑reviewed evidence — how to tell the difference
Many of the documents in the search results are PR releases, brand pages, or affiliate reviews that repeat a company’s trial claims [1] [2] [5]. Independent reviewers and health journalists warn readers to look for peer‑reviewed publications and transparent methods; several sources explicitly note that company claims often outpace publicly available, independently reviewed data [4] [8].
6. Practical takeaways for men over 50 considering supplements
If you are over 50 and considering a supplement to increase semen volume, the reporting advises consulting a clinician first because (a) underlying medical causes or medications may be responsible for changes in semen volume and (b) the trial evidence for finished supplements in older men is sparse or not age‑specific [3] [4]. Where trials are cited (e.g., Semenax), they involve mixed‑age cohorts and are reported mainly in company‑linked material rather than broad independent literature [1] [2].
7. What reporting does not say or does not include
Available sources do not publish peer‑reviewed, large randomized trials specifically in men over 50 that demonstrate a reliable, clinically meaningful increase in semen volume from OTC supplements (not found in current reporting). They also do not provide detailed subgroup results isolating effects in the 50+ age bracket from the cited trials [1] [2] [4].
Summary recommendation: Treat brand trial claims with skepticism, seek peer‑reviewed evidence and medical advice, and recognize that current public reporting documents only limited, often company‑sponsored trials with mixed‑age samples rather than robust, independently replicated studies focused on men over 50 [1] [2] [3] [4].